Cargando…
Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients
Chemotherapy-induced amenorrhea (CIA) is a side effect that occurs in patients with breast cancer (BC) as a result of chemotherapy. These patients require special treatments to avoid infertility and menopause. However, the factors controlling CIA, resumption of menstruation (RM), and persistence of...
Autores principales: | Jeon, Se Jeong, Lee, Jae Il, Jeon, Myung Jae, Lee, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998816/ https://www.ncbi.nlm.nih.gov/pubmed/27057900 http://dx.doi.org/10.1097/MD.0000000000003301 |
Ejemplares similares
-
Primary amenorrhea after bone marrow transplantation and adjuvant chemotherapy misdiagnosed as disorder of sex development: A case report
por: Huang, He, et al.
Publicado: (2016) -
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
por: Bianco, A. R., et al.
Publicado: (1991) -
Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case–control study
por: Tak, Young Jin, et al.
Publicado: (2016) -
Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors
por: Cao, Guang-Shao, et al.
Publicado: (2018) -
Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer
por: Wang, Jiayu, et al.
Publicado: (2015)